Marksans Pharma Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Plot No L-82 & L-83, Verna Industrial Estate,, Verna, Goa 403722, India (IND)
- Operations here
- manufacture
- FDA identifiers
- FEI 3006230648 · DUNS 925822975
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-04-17
- VAIBioresearch Monitoring2023-08-04
- VAIDrug Quality Assurance2017-04-07
- NAIDrug Quality Assurance2015-09-03
- NAIDrug Quality Assurance2012-08-03
- VAIDrug Quality Assurance2009-11-13
Drugs this plant is listed as making
14 distinct drugs across 48 products name this site in their FDA label.
- Benzonatate 100 mgMarksans Pharma Limited
- Benzonatate 200 mgMarksans Pharma Limited
- Duloxetine HydrochlorideMarksans Pharma Limited
- DutasterideMarksans Pharma Limited
- Fluoxetine HydrochlorideTime Cap Laboratories, Inc.
- GabapentinMarksans Pharma Limited
- IbuprofenMarksans Pharma Limited
- Metformin HClTime Cap Laboratories, Inc
- Metformin HydrochlorideTime Cap Laboratories, Inc
- NaproxenTime Cap Laboratories
- ParicalcitolMarksans Pharma Limited
- PregabalinMarksans Pharma Limited
- Valacyclovir HydrochlorideTime Cap Laboratories, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.